Sectors
ADCT
ADC Therapeutics SA
1.30
1 x 0.55
1 x 2.05
bid
ask
+
0.02
1.56%
20 @ 04:01 AM
1.29 -0.01 (0.77%)
| Ytd | -63.17% | |
| 1y | -58.73% |
1.24
day range
1.33
0.78
52 week range
4.97
| Open | 1.29 | Prev Close | 1.28 | Low | 1.24 | High | 1.33 | Mkt Cap | 165.35M |
| Vol | 547.72K | Avg Vol | 1.94M | EPS | -1.05 | P/E | N/A | Forward P/E | -1.36 |
| Beta | 1.87 | Short Ratio | 6.98 | Inst. Own | 61.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 2.40 | 200-d Avg | 3.58 | 1yr Est | 8.40 |
ADCT News
benzinga.com
ADC Therapeutics Completes Enrollment In LOTIS-7 Phase 1b Open-Label Clinical Trial Evaluating ZYNLO
100 r/r DLBCL patients treated at the selected 150 µg/kg dose of ZYNLONTA® plus glofitamabFull data
benzinga.com
ADC Therapeutics Announces Strategic Reorganization To Focus Resources Behind Key Value-Driving Init
Planned ~17% workforce reduction expected to generate annualized estimated savings of approximately